ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05340	Primary immunodeficiency	9/51	30/7206	2.71256421961e-13
ko04060	Cytokine-cytokine receptor interaction	15/51	191/7206	1.78586970694e-12
ko04659	Th17 cell differentiation	9/51	106/7206	4.16555494019e-08
ko04612	Antigen processing and presentation	8/51	77/7206	5.16255173675e-08
ko05310	Asthma	5/51	17/7206	8.43229264344e-08
ko05321	Inflammatory bowel disease (IBD)	7/51	56/7206	1.03412483461e-07
ko05145	Toxoplasmosis	9/51	126/7206	1.87846807875e-07
ko05330	Allograft rejection	5/51	24/7206	5.57965536644e-07
ko05320	Autoimmune thyroid disease	5/51	29/7206	1.51791687978e-06
ko04658	Th1 and Th2 cell differentiation	7/51	96/7206	4.28661407519e-06
ko04640	Hematopoietic cell lineage	6/51	64/7206	5.09514134836e-06
ko04672	Intestinal immune network for IgA production	5/51	37/7206	5.33893186698e-06
ko05164	Influenza A	8/51	167/7206	1.91724638549e-05
ko05416	Viral myocarditis	5/51	55/7206	3.87110924863e-05
ko04064	NF-kappa B signaling pathway	6/51	96/7206	5.30489962067e-05
ko05140	Leishmaniasis	5/51	75/7206	0.000172658636554
ko05332	Graft-versus-host disease	3/51	18/7206	0.000252892616849
ko05144	Malaria	4/51	45/7206	0.000267750405643
ko04514	Cell adhesion molecules (CAMs)	6/51	130/7206	0.000284282070857
ko05152	Tuberculosis	7/51	187/7206	0.000312033606648
ko04620	Toll-like receptor signaling pathway	5/51	100/7206	0.000659390781078
ko04145	Phagosome	6/51	162/7206	0.000917723755136
ko04940	Type I diabetes mellitus	3/51	32/7206	0.00143355491366
ko05168	Herpes simplex infection	6/51	182/7206	0.00167473721413
ko05150	Staphylococcus aureus infection	3/51	36/7206	0.00202296583933
ko04630	Jak-STAT signaling pathway	5/51	132/7206	0.00228580285801
ko04062	Chemokine signaling pathway	6/51	201/7206	0.00276614830548
ko05323	Rheumatoid arthritis	4/51	89/7206	0.0034908489757
ko05322	Systemic lupus erythematosus	5/51	151/7206	0.00408832493354
ko05162	Measles	4/51	120/7206	0.0100051050288
ko05166	HTLV-I infection	6/51	292/7206	0.0163531051626
ko04650	Natural killer cell mediated cytotoxicity	3/51	97/7206	0.0309171242307
ko00980	Metabolism of xenobiotics by cytochrome P450	2/51	40/7206	0.0322821640803
ko05204	Chemical carcinogenesis	2/51	48/7206	0.045050830073